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DOT-ELISA FOR EVALUATION OF HYDATID CYST WALL, PROTOSCOLECES AND HYDATID CYST
FLUID ANTIGENS IN THE SERODIAGNOSIS OF CYSTIC ECHINOCOCCOSIS
S.R. SWARNA & Subhash Chandra PARIJA
SUMMARY
The aim of the present study is to evaluate cyst wall and protoscolex as an alternate source of antigen in serodiagnosis of cystic
echinococcosis (CE). A total of 90 blood samples, 30 each of confirmed CE cases, disease controls and healthy controls were
collected. Dot-ELISA using cyst wall, protoscolex and cyst fluid were used to demonstrate anti-hydatid antibodies. The sensitivity
of Dot-ELISA using cyst wall, protoscolex and cyst fluid was 96.66%, 86.66% and 93.33% respectively and the specificity of the
assay was 70% for Dot-ELISA using cyst fluid, protoscolex and cyst wall antigens. Results of the present study show that cyst wall
and protoscolex can also be an useful source of antigen in detection of hydatid antibodies in the serodiagnosis of CE.
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INTRODUCTION
Cystic echinococcosis (CE) is a zoonotic disease that is common
in rural population of underdeveloped countries because of their close
association with domestic and wild animals14. CE in human is mostly
asymptomatic throughout the life in a majority of cases. In symptomatic
cases, the clinical manifestations are highly variable and non-specific
and depend on the organ infected with the cyst, number of the cysts,
size of the cysts and their sites within the involved organ, interaction
between the expanding cysts and adjacent organ, and complications
caused by rupture of cysts19,24. Moreover, incubation period varies from
few months to several years. Hence, there is difficulty in the clinical
diagnosis of this condition.
In the absence of specific clinical features, early detection of the
developing hydatid cyst in the cases depends more upon the laboratory
procedures that is essential to initiate appropriate chemotherapy or
surgery. Diagnosis of CE involves imaging methods, supplemented by
immunological methods. Imaging methods in combination with
immunological methods are now extensively used to support clinical
diagnosis of the condition6,15,17,23. During the last two decades,
tremendous advance has been made in both these fields, which have a
direct bearing on the diagnosis of CE in humans as well as in animals.
Imaging methods are often too costly and are not available in most
of the endemic areas. Thus, serodiagnosis plays the most important
role in the diagnosis of CE because of their low cost and ease of
performance. Serodiagnosis based on the detection of anti-
Echinococcus antibodies in the serum, remains the mainstay in the
laboratory diagnosis of CE3,25.
Hydatid cyst fluid is the most commonly used source of antigen
for detection of hydatid antibodies in the serum. Several serological
tests using crude hydatid cyst fluid have been developed with
considerable difference in both specificity and sensitivity for the
diagnosis of CE5. Variation in sensitivity and specificity due to the
difference in preparation of antigen and standardization of the technique
has led to the use of newer metacestode antigens such as protoscolex
antigen, cyst wall antigen and adult worm antigen in the diagnosis of
CE4,9,18.
In the present study, Dot-ELISA, a simple and rapid microassay is
used to evaluate cyst wall and protoscolex as source of antigen in the
serodiagnosis of CE.
MATERIALS AND METHODS
Study groups: The present study is conducted in the Department
of Microbiology of Jawaharlal Institute of Postgraduate Medical
Education and Research (JIPMER) Hospital, Pondicherry. Samples are
collected from the patients with CE, patients with other diseases, healthy
students and blood donors. The informed consent is obtained from all
human adult participants.
The Groups included:
Group 1 - Surgically confirmed and ultrasound diagnosed cystic
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echinococcosis (n = 30): The group included 10 cases of surgically
confirmed and 20 cases of ultrasound diagnosed cases of CE.
The cysts removed during surgery are confirmed to be of hydatid
cyst etiology by histopathological evidence of germinal layer in the
wall of the cyst and demonstration of protoscoleces and hooklets in
the aspirated cyst fluid.
Ultrasound-diagnosed CE cases included non-operated cases of CE
but diagnosed by ultrasonography. The cysts, which showed daughter
cysts or prominent septation, and pathognomonic hydatid sands in cysts
by ultrasound, are diagnosed as ultrasound-diagnosed CE.
Group 2 - Controls with other parasitic diseases (n = 30): This
group included patients with other parasitic diseases other than CE
like amoebiasis, filariasis, neurocysticercosis and toxoplasmosis.
Group 3 - Healthy controls (n = 30): This group included healthy
adults (blood donors and students) who have not suffered from CE or
any other disease in the recent past.
Serum: Five milliliters of venous blood is collected from all cases
of surgically confirmed and ultrasound diagnosed CE (n = 30), controls
with other parasitic diseases (n = 30) and healthy controls (n = 30)
under aseptic precautions and is allowed to clot. The serum is separated
and stored in duplicate at -20 0C till use. Sodium azide (0.05 mol/L) is
used as preservative.
Preparation of somatic hydatid antigens: The hydatid cysts from
the liver of human patients are collected after surgery. Three somatic
antigen preparations are made from the same cysts and designated as
hydatid cyst fluid (HCF) antigen, hydatid protoscolex (HPR) antigen,
and hydatid cyst wall (HCW) antigen.
1. Preparation of hydatid cyst fluid (HCF) antigen: The HCF
antigen is prepared as per the method described by KANWAR et al.7.
The HCF is aspirated aseptically from the fertile hydatid cyst and is
collected in sterile centrifuge tube. The HCF is centrifuged at 1500 g
for 30 min at 4 ºC, dialyzed extensively against distilled water. To this,
0.5M of phenylmethylsulfonyl fluoride (PMSF) is added at a proportion
of 1/100 and stored at -20 ºC.
2. Preparation of hydatid protoscolex (HPR) antigen: The HPR
antigen is prepared as per the method described by RAFIEI & CRAIG18.
In this procedure, the HCF is centrifuged at 1500 g for 30 min at 4 ºC,
and the sediment containing protoscoleces is collected in a sterile tube.
The protoscoleces are washed three times with PBS 7.2. The washed
protoscoleces are then subjected to three cycles of freezing and thawing
and resuspended in 10 volumes of PBS 7.2 containing 0.5M PMSF (at
a ratio of 1 in 100). The HPR suspension is then sonicated on ice in a
150w ultrasonic disintegrator, in 10-second bursts with five seconds
intervals, until no intact protoscoleces are visible microscopically. The
sonicate is left at 4 ºC overnight and then centrifuged at 14,500 g for
30 min. The supernatant is collected, dispensed in small aliquots and
stored as HPR antigen at -20 ºC.
3. Preparation of hydatid cyst wall (HCW) antigen: The HCW
antigen is prepared as per the method described by RAFIEI & CRAIG18.
After aspiration of HCF, the collapsed HCW is washed three times in
PBS 7.2 and homogenized using mortar and pestle. The homogenized
tissue is collected in a sterile container and kept at -20 ºC overnight.
Then, it is thawed and sonicated on ice in a 150w ultrasonic disintegrator,
in 60 sec bursts with ficccve second intervals, until no intact tissue bits
are visible through naked eye. 0.5M of PMSF (at a ratio of 1 in 100) is
added to the sonicated suspension and is left at 4 ºC overnight and then
centrifuged at 14,500 g for 30 min. The supernatant is collected, dispensed
in small aliquots and stored as HCW antigen at -20 ºC.
Protein content of each antigen preparations is estimated by
standard method of LOWRY8 and readings are taken at 660 nm in an
UV-visible spectrophotometer (Cintra 5, Australia), aliquoted to 1 mL
cryoprotected vials and stored at -20 0C.
Dot-ELISA: The Dot-ELISA is performed by using three different
antigens (crude extract of HCW antigen, HPR antigen and HCF antigen)
for the detection of IgG antibodies in the same batch of serum samples
from cases of CE and controls. The optimization of Dot-ELISA
conditions are performed to know the concentration of antigen to be
dotted and the dilution of serum used.
Dot-ELISA using the HCF antigen for detection of antibodies
consisted of following steps:
1 Antigen coating: A nitrocellulose membrane (NCM) (Hybond ECL,
Amersham bioscience, Germany) of size 0.5 x 0.5 cm is cut and
mounted onto a plastic strip (0.5 cm x 5 cm). A volume of
2 µL/strip (5 µg/strip) of HCF antigen is dotted on to individual
strips and air dried for 30 min.
2 Washing: The un-adsorbed antigen is removed by washing the strips
with washing buffer (sterile PBS 7.2 containing 0.1% Tween-20
(PBS-T) is used as the washing buffer).
3 Blocking: The uncoated reactive sites in the strips are blocked by
PBS 7.2 containing 2% BSA by incubating for three hours at 37 °C
with constant shaking.
4 Washing: Strips are washed three times with PBS-T as described
before.
5 Sample serum dilution and incubation: 1:1000 dilution of the patient
sera is prepared in PBS-T and the strips are incubated for 1.5 hours
at 37 0C with constant shaking.
6 Washing: The strips are washed three times with PBS-T as before
to remove unbound antibodies in the sample serum.
7 Secondary antibody (conjugate) incubation: 1:2000 dilution of
rabbit anti-human-IgG-HRP conjugated secondary antibody
(Bangalore Genie, India) is used as per the manufacturer’s
instruction with PBS 7.2 containing Tween-20 (0.1%) and incubated
for 0.5 hours at 37 0C in the dark in a rocker shaker.
8 Washing: Strips are washed three times with PBS-T as before to
remove unbound conjugate.
9 Colour development: Substrate solution is prepared freshly by
adding 3 mg of 3, 3’ diaminobenzidine (DAB) (Sigma, USA) in 5
mL of PBS 7.2 containing 0.1% Tween-20 and 5 µL H2O2 is addedjust before adding to the plastic tray. The strips are dispensed and
incubated for 15-20 minutes at 37 0C in dark under constant rocking
for the development of colour.
10 Stop reaction: The reaction is stopped by washing with double
distilled water.
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The positive reaction is indicated by the development of brown
coloured spot in 2 - 5 minutes. When the reaction is complete, the
strips are washed with distilled water and allowed to dry. Once dried,
the strips are stored in the dark.
The same Dot-ELISA procedure is repeated by using separately with
2 µL of crude antigens of HPR and HCW antigens. The Dot-ELISA
using all these antigens are tested for IgG antibodies in the same batch
of serum samples from cases of CE and controls as mentioned earlier.
Statistical analysis: Sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and efficiency of the diagnostic
methods are calculated as per the standard method16. Statistical
difference between serological tests is compared by univariate statistical
test, χ2 using Epi info 2001. In all these tests, a p-value of < 0.05 is
considered indicative of a statistically significant difference.
RESULTS
The results of Dot-ELISA using crude extract of HCW antigen,
HPR antigen and HCF antigen for detection of hydatid antibodies in
serum from the cases of CE and controls is summarized in Table 1.
An optimum concentration of 5 µg separately of HCF, HPR and
HCW antigen per dot could detect specific anti-hydatid IgG antibodies
at 1:1000 serum dilutions of sera from CE cases.
Dot-ELISA using HCF antigen demonstrated diagnostic level of
antibodies in 28 out of 30 (93.33%) sera of confirmed cases of CE (Group-
I). The test also detected antibodies in 43.33% sera of parasitic disease
controls (Group-II) and 16.66% sera of healthy controls (Group III).
Dot-ELISA using HPR antigen demonstrated diagnostic level of
antibodies in 26 out of 30 (86.66%) sera of confirmed cases of CE (Group-
I). The test also detected antibodies in 40% sera of parasitic disease
controls (Group-II) and 20% sera of healthy controls (Group III).
Dot-ELISA using HCW antigen demonstrated diagnostic level of
antibodies in 29 out of 30 (96.66%) sera of the cases with confirmed
CE (Group-I). The test also detected antibodies in 43.33% sera of
parasitic disease controls (Group-II) and 16.66% sera of healthy controls
(Group III).
Statistical analysis: The sensitivity, specificity, PPV, NPV and
efficiency of the Dot-ELISA carried out with crude extract of HCW,
HPR and HCF antigens for detection of hydatid IgG antibodies in serum
are presented in Table 2.
DISCUSSION
Dot-ELISA is a highly versatile solid-phase immunoassay for antibody
detection in the diagnosis of leishmaniasis11, toxoplasmosis13, malaria13,
trypanosomiasis1, cysticercosis2 and CE22. The assay uses minute amounts
of reagents dotted onto solid surfaces such as nitrocellulose or cellulose
acetate membranes, which avidly bind proteins13. After incubation with
antigen-specific antibody and enzyme-conjugated anti-antibody, the
addition of a precipitable, chromogenic substrate causes the formation of
a colored dot on the solid phase, which is visually read.
In the present study, the Dot-ELISA using HCW, HPR and HCF
antigens separately, showed a sensitivity of 93.33%, 86.66% and
96.66% respectively, for detection of specific hydatid antibodies in
serum (Table 2).
The sensitivity of Dot-ELISA obtained using HCF (93.33%), HPR
(86.66%) and HCW (96.66%) antigens separately in the present study
is in agreement with the results of PAPPAS et al.11. In their study, Dot-
ELISA using sheep HCF antigens showed a sensitivity of 96% and
specificity of 98%. Cross-reactions were observed with sera from
patients with cysticercosis, filariasis, toxocariasis, trichinosis, visceral
larva migrans, and liver cirrhosis. Only one false-positive reaction was
observed by the Dot-ELISA when 52 sera from healthy subjects were
assayed. They observed that the Dot-ELISA is a rapid and economical
enzyme immunoassay, which is very antigen-conservative, requires
only nanogram quantities of parasite antigen and serum conservative
and needs only 50 microliter of diluted patient serum12.
In another study, the bovine hydatid antigen was used to develop a
simple and fast in vitro diagnostic assay for CE10. The procedure of Dot-
ELISA consisted of incubation of the serum sample with a textile colloidal
dye (pink) and a nitrocellulose stick to which the hydatid antigen was
bound. The presence of parasite-specific antibodies results in dyeing of
the stick reactive area and appearance of a colored spot. Dot-ELISA showed
positive results in all the patient sera and in none of the control sera. The
test showed a good predictive value, allowing a speedy diagnosis of CE10.
Table 2
Diagnostic evaluation of Dot-ELISA for diagnosis of cystic echinococcosis
Diagnostic evaluation of Dot-ELISA
for detection of hydatid antibodies
Diagnostic evaluation in serum using
criteria HCF HPR HCW
Sensitivity 93.33% 86.66% 96.66%
Specificity 70% 70% 70%
Diagnostic efficiency 88.33% 83.33% 90%
Positive predictive value 60.86% 59.09% 61.70%
Negative predictive value 92.59% 85.71% 96.15%
Table 1
Detection of total IgG antibodies in serum of CE cases and controls by Dot-
ELISA using HCF, HPR and HCW antigens for diagnosis of cystic
echinococcosis
Subject groups Antibody positive in serum by Dot-ELISA using
(n = 120) HCF HPR HCW
Confirmed cases 28 (93.33%) 26 (86.66%) 29 (96.66%)
(n = 30)
Disease controls 13 (43.33%) 12 (40%) 13 (43.33%)
(n = 30)
Healthy controls 5 (16.66%) 6 (20%) 5 (16.66%)
(n = 30)
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Dot-ELISA was also found to be 88.9% sensitive, 96.9% specific for rapid
diagnosis of CE by demonstration of hydatid antibodies in the sera21.
In the present study, the specificity of Dot-ELISA is 70% using
HCF, HPR and HCW antigens (Table 2). The moderate specificity
obtained in the present study is due to cross-reaction with sera from
neurocysticercosis, filariasis and amoebiasis. ROGAN et al.20 reported
lower specificity (52%) and higher sensitivity (97%) with the use of
crude sheep HCF. They have also observed cross-reactions with sera
from patients with cysticercosis, filariasis, toxocariasis and trichinosis.
It is suggested that the cross reaction was due to the use of a crude and
complex HCF preparation containing shared helminth antigens22.
In the present study, the use of HCW and HPR antigens along with
HCF antigens in Dot-ELISA for the diagnosis of CE showed that there
is no significant difference in the sensitivity of Dot-ELISA (p = 0.785)
using either of HCW, HPR and HCF antigens. No significant difference
in the sensitivity of the Dot-ELISA by using HCW, HPR and HCF
antigens, suggests that HPR and HCW could also be used as antigen
apart from HCF, which is routinely used in the serodiagnosis of CE.
RESUMO
Dot-Elisa para avaliação da parede do cisto hidático,
protoscoleces e antígenos do fluido do cisto hidático no
sorodiagnóstico da equinococose cística
O propósito do presente trabalho é avaliar a parede cística e
protoscolex como fontes alternativas de antígeno no sorodiagnóstico de
equinococose cística (CE). De um total de 90 amostras de sangue, foram
coletadas 30 de casos CE confirmados, 30 de controles de doença e 30
controles saudáveis. Dot-Elisa usando parede cística, protoscolex e fluido
cístico foi utilizada para demonstrar anticorpos anti-hidáticos. A
sensitividade de Dot-Elisa usando parede cística, protoscolex e fluido
cístico foi de: 96,66%, 86,66% e 93,33% respectivamente e a
especificidade do ensaio de 70% para Dot-Elisa usando fluido cístico,
protoscolex e antígeno da parede cística. Resultados do presente estudo
mostram que parede cística e protoscolex podem ser fontes úteis de
antígeno na detecção de anticorpos hidáticos no sorodiagnóstico do CE.
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